International Journal of Health Policy and Management

Number of Articles: 2170

Articles in Press: ALL Accepted Manuscript Corrected Proof

Barriers Toward the National Program for Prevention and Control of Diabetes in Iran: A Qualitative Exploration

Volume 12, Issue 1, 2023, Pages 1-8

10.34172/ijhpm.2022.6908

Sohila Sadeghi, Fatemeh Mahani, Parisa Amiri, Shahram Alamdari, Davood Khalili, Navid Saadat, Seyed Alireza Ebadi, Ali Reza Mahdavi Hazaveh, Mohammad Karim Shahrzad, Fereidoun Azizi

Discrepancies Among Hospitals and Regions in the Provision of Low-Value Care

Volume 13, Issue 1, 2024, Pages 1-10

10.34172/ijhpm.2024.7876

Yu-Chen Kuo, Kuan-Chia Lin, Elise Chia-Hui Tan

Impact of China’s National Volume-Based Drug Procurement: A Multilevel Interrupted Time Series Analysis on Medical Expenditures in Hypertensive Patients

Volume 14, Issue 1, 2025, Pages 1-14

10.34172/ijhpm.8540

Yunxiang Huang, Yan Ren, Yuanjin Zhang, Yulong Jia, Qianrui Li, Minghong Yao, Yuning Wang, Fan Mei, Kang Zou, Huangang Hu, Jing Tan, Xin Sun

The Consequences of Performance Measurement Systems in Multilevel Governance Health Systems: The Case of the Italian National Healthcare Service

Volume 15, Issue 1, 2026, Pages 1-16

10.34172/ijhpm.9384

Federico Rotondo, Lucia Giovanelli, Nicoletta Fadda, Russell Mannion

The Embedded Health Management Academic: A Boundary Spanning Role for Enabling Knowledge Translation; Comment on “CIHR Health System Impact Fellows: Reflections on ‘Driving Change’ Within the Health System”

Volume 9, Issue 4, April 2020, Pages 170-174

10.15171/ijhpm.2019.108

Kathy Eljiz, David Greenfield, Robyn Taylor

Independent Treatment Centres Are Not a Guarantee for High Quality and Low Healthcare Prices in The Netherlands – A Study of 5 Elective Surgeries

Volume 9, Issue 9, September 2020, Pages 380-389

10.15171/ijhpm.2019.144

Anouk Dorine Maria Tulp, Florien Margareth Kruse, Niek Waltherus Stadhouders, Patrick P.T. Jeurissen

Public-Private Partnerships With Unhealthy Commodity Industries: Are They Undermining Real Progress in NonCommunicable Disease Prevention?; Comment on “Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-communicable Diseases”

Volume 11, Issue 7, July 2022, Pages 1212-1214

10.34172/ijhpm.2021.118

Chiara Rinaldi

Six Honest Serving Matters, Teaching Us all We Need to Know About Context in Knowledge Implementation?; Comment on "Stakeholder Perspectives of Attributes and Features of Context Relevant to Knowledge Translation in Health Settings: A Multi-Country Analysis"

Volume 11, Issue 8, August 2022, Pages 1574-1576

10.34172/ijhpm.2021.152

Ann Catrine Eldh

Articulating Concepts Matters! Resilient Actions in the Norwegian Governmental Response to the COVID-19 Pandemic; Comment on “Government Actions and Their Relation to Resilience in Healthcare During the COVID-19 Pandemic in New South Wales, Australia and Ontario, Canada”

Volume 11, Issue 9, September 2022, Pages 1945-1948

10.34172/ijhpm.2022.6892

Sina Furnes Øyri, Siri Wiig

Systems Science and Evidence-Informed Deliberation to Mitigate Dilemmas in Situations of Dual Agency at the Hospital Level; Comment on “Dual Agency in Hospitals: What Strategies Do Managers and Physicians Apply to Reconcile Dilemmas Between Clinical and Economic Considerations”

Volume 11, Issue 10, October 2022, Pages 2337-2339

10.34172/ijhpm.2022.6940

Leon Bijlmakers

Situating Food Industry Influence: Governance Norms and Economic Order; Comment on “‘Part of the Solution’: Food Corporation Strategies for Regulatory Capture and Legitimacy”

Volume 11, Issue 11, November 2022, Pages 2736-2739

10.34172/ijhpm.2022.7197

Raphael Lencucha

Beyond Organisational Borders: The Soft Power of Innovation in the Health Sector; Comment on “What Managers Find Important for Implementation of Innovations in the Healthcare Sector – Practice Through Six Management Perspectives”

Volume 11, Issue 12, December 2022, Pages 3125-3128

10.34172/ijhpm.2022.7270

Cátia Miriam Costa

Improving Insurance Protection for Rare Diseases: Economic Burden and Policy Effects — Simulation of People With Pompe Disease in China

Volume 12, Issue 1, 2023, Pages 1-13

10.34172/ijhpm.2022.6282

Shanquan Chen, Dong Dong

Association of Launch Price and Clinical Value With Reimbursement Decisions for Anticancer Drugs in China

Volume 13, Issue 1, 2024, Pages 1-10

10.34172/ijhpm.2024.8150

Jing Zhou, Hao Lu, Jay Pan

Engaging Councillors to Address Structural and Social Drivers of HIV Infections in Blantyre City: A Formative Study

Volume 14, Issue 1, 2025, Pages 1-10

10.34172/ijhpm.8550

Edna N. Bosire, Victor Mwapasa, Emily Mendenhall, Sara Allinder, Deborah Hoege, Pilira Chirambo, Emmanuel Kanjunjunju, Gift Kawalazira, Yohane Kamwigira, Tione Chilambe, Charles B. Holmes